SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-224776
Filing Date
2020-08-19
Accepted
2020-08-19 17:17:28
Documents
2
Group Members
NIMCO US, INC., NESTLE S.A., NESTLE US HOLDCO, INC., SOCIETE DES PRODUITS NESTLE S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d18424dsc13da.htm SC 13D/A 138956
2 EX-99.2 d18424dex992.htm EX-99.2 6800
  Complete submission text file 0001193125-20-224776.txt   147469
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Subject) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88909 | Film No.: 201117845
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203
Business Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203 (818) 548-7050
Nestle Health Science US Holdings, Inc. (Filed by) CIK: 0001644164 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A